EUVIMEDEUVIMED entdecken
Crossref

Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia

E Stikeman, D Bianco

Journal of Small Animal Practice · 2024

DOI: 10.1111/jsap.13700 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Small Animal Practice, 2024. Verfasst von E Stikeman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Metropolitan Animal Specialty Hospital, 6565 Santa Monica Boulevard, Los Angeles, CA, 90038, USA. Hauptthemen laut MEDLINE: Dog Diseases, Immunoglobulins, Intravenous, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives To evaluate the safety and efficacy of human intravenous immunoglobulin in dogs with newly diagnosed malignancy and presumed secondary immune‐mediated thrombocytopenia. Materials and Methods Twelve client‐owned dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia were prospectively enrolled to receive a single infusion of human intravenous immunoglobulin at a dose of 0.5 to 1 mg/kg intravenous over 8 hours. A complete treatment response was defined as a platelet estimation of ≥40,000 platelets/μL within 24 hours and a partial response within 48 hours from the completion of human intravenous immunoglobulin infusion. No treatment response was defined as a platelet estimation remaining

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesImmunoglobulins, IntravenousNeoplasmsDogsAnimalsMaleFemalePilot ProjectsProspective StudiesHumansPurpura, Thrombocytopenic, IdiopathicTreatment OutcomeThrombocytopenia

Substanzen

Immunoglobulins, Intravenous

Autor:innen und Institutionen

  • Internal Medicine Department, Metropolitan Animal Specialty Hospital, 6565 Santa Monica Boulevard, Los Angeles, CA, 90038, USA.

Zitieren

APA

Stikeman, E., & Bianco, D. (2024). Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia. Journal of Small Animal Practice. https://doi.org/10.1111/jsap.13700

Vancouver

Stikeman E, Bianco D. Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia. Journal of Small Animal Practice. 2024. doi:10.1111/jsap.13700

BibTeX
@article{Stikeman2024,
  author = {Stikeman, E and Bianco, D},
  title = {Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia},
  journal = {Journal of Small Animal Practice},
  year = {2024},
  doi = {10.1111/jsap.13700}
}
Kostenlos starten →